Self-sustaining interleukin-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19
Authors
- R. Kaiser
- A. Leunig
- K. Pekayvaz
- O. Popp
- M. Joppich
- V. Polewka
- R. Escaig
- A. Anjum
- M.L. Hoffknecht
- C. Gold
- S. Brambs
- A. Engel
- S. Stockhausen
- V. Knottenberg
- A. Titova
- M. Haji
- C. Scherer
- M. Muenchhoff
- J.C. Hellmuth
- K. Saar
- B. Schubert
- A. Hilgendorff
- C. Schulz
- S. Kääb
- R. Zimmer
- N. Hübner
- S. Massberg
- P. Mertins
- L. Nicolai
- K. Stark
Journal
- JCI Insight
Citation
- JCI Insight 6 (18): e150862
Abstract
Neutrophils provide a critical line of defense in immune responses to various pathogens, but also inflict self-damage upon transition to a hyperactivated, procoagulant state. Recent work has highlighted proinflammatory neutrophil phenotypes contributing to lung injury and acute respiratory distress syndrome (ARDS) in patients suffering from COVID-19. Here, we utilize state-of-the art mass spectrometry-based proteomics, transcriptomic and correlative analyses as well as functional in vitro and in vivo studies to dissect how neutrophils contribute to the progression to severe COVID-19. We identify a reinforcing loop of both systemic and neutrophil intrinsic interleukin-8 (CXCL8/IL-8) dysregulation, which initiates and perpetuates neutrophil-driven immunopathology. This positive feedback loop of systemic and neutrophil autocrine IL-8 production leads to an activated, prothrombotic neutrophil phenotype characterized by degranulation and neutrophil extracellular trap (NET) formation. In severe COVID-19, neutrophils directly initiate the coagulation and complement cascade, highlighting a link to the immunothrombotic state observed in these patients. Targeting the IL-8-CXCR-1/-2 axis interferes with this vicious cycle and attenuates neutrophil activation, degranulation, NETosis, and IL-8 release. Finally, we show that blocking IL-8-like signaling reduces SARS-CoV-2 spike protein-induced, hACE2-dependent pulmonary microthrombosis in mice. In summary, our data provide comprehensive insights into the activation mechanisms of neutrophils in COVID-19 and uncover a self-sustaining neutrophil-IL-8-axis as promising therapeutic target in severe SARS-CoV-2 infection.